Adolescents, Autonomy and Medical Treatment. Divergence and convergence across the globe

Sous la direction de Brigitte Feuillet-Liger, Ryuichi Ida et Thérèse Callus, cet ouvrage est paru chez Bruylant en juin 2012
Adolescents, Autonomy and Medical Treatment. Divergence and convergence across the globe


Although adolescence cannot be said to be a medical condition, and although most adolescents are healthy, some do become ill. But the adolescent is not a patient like any other...Today, the age of majority is set in most jurisdictions at the age of 18 years, but in the context of medical treatment, many countries do recognise a certain level of autonomy (to a greater or lesser extent) of adolescents who are deemed to be mature. However, the extent of this autonomy raises many questions. Is the consent of the adolescent required, along with that of the parents, before any intervention may take place? Do they have a right of veto? Is their consent alone enough? Are they recognised as having the right to take part in medical trials, the right to refuse necessary treatment...?

These and many other questions are at the heart of this multidisciplinary and international study, which is the fruit of reflection and discussion between lawyers, philosophers, sociologists and child psychologists during the 2nd Workshop of the International Academic Network on Bioethics. The issues raised go well beyond law because they engender questions of the individuality of the adolescent and her ability to make choices when faced with illness and even her own death. Despite the complexity and depth of the subject, the chapters in this volume clearly reveal the status of the adolescent in medical decisionmaking, in sixteen different countries. Despite obvious differences between the systems studied, the one thing that is clear is the gradual recognition of the adolescent’s growing autonomy in medical decisionmaking which is not always expressly provided for in legislation. Such an evolution is hardly surprising at a time when the distinction between adolescence and adulthood is becoming less certain for many.

Created in 2007, the IANB’s objective is to promote research through collaboration between academic representatives from different countries and cultures, all specialists in the field of biomedicine. Based upon a comparative approach of different legal systems, the work of the group analyses social choices in biomedicine through the different lenses of ethics, anthropology, philosophy and sociology. In this way, their research feeds into the elaboration and development of international regulation of biomedical practices and incidentally on achieving the balance between the respect for different cultures and the move towards a certain universality, supporting the harmonisation of laws. This new collection will therefore be indispensable for anyone seeking to understand the social implications of bioethics.


Roselyne BACHELOT-NARQUIN (préface), Pénélope AGALLOPOULOU, Amel AOUIJ-MRAD et Salwa HAMROUNI, Stéphane BAUZON, Thérèse CALLUS, Maria-Claudia CRESPO-BRAUNER et Anderson LOBATO, Brigitte FEUILLET-LIGER, Françoise FURKEL, Ryuichi IDA, Francis KERNALEGUEN, Pierre LE COZ, David LE BRETON, Dominique MANAI, Kristina ORFALI, André PEREIRA, Verónica SAN JULIAN, Marcel RUFO et Mohamed Amine BENJELLOUN et Guillaume BRONSARD, Alain ROY, Judit SANDOR, Geneviève SCHAMPS, JG SIJMONS.